This is in concordance with published findings demonstrating the alteration of CSC-like phenotype in head and neck squamous cell carcinoma treated with the HDAC inhibitors, TSA and SAHA25. The gene discussed is HDAC9; the disease is head and neck squamous cell carcinoma.